Haemostatic agents, on the other hand, are agents that promote or facilitate the blood clot during surgical procedures. Not to confuse them with the hemostats that are devices which are used to control bleeding during operations.
Have you ever wondered that whenever you get wounded or hurt, what natural process causes the bleeding to stop? It is hemostasis. A coordinated effort of multiple platelets, proteins, and numerous other factors assist in stopping the blood from oozing out by forming proper clots.
The global Haemostatic Agents Market is expected to grow significantly. Several reports suggest that the compound annual growth rate or the CAGR for the market would be close to 4.0%. As a result of which the industry is supposed to clock $6.70 billion by 2021.
Major reasons for the market to boom in a drastic way are an increasing geriatric population, chronic diseases, increasing surgery volumes, and a growing awareness among medical professionals that it could be used on a large commercial scale. The adoption rate, however, remains slower in upcoming economies. Nevertheless, the Haemostatic agents market in Latin America and the Middle East might be slow to gain traction due to exorbitant device cost.
In spite of visible challenges, the market can grow. There are different reasons that back up the forecast. The market is nascent and still emerging. Therefore, it makes it a curious deal and product for the emerging countries to invest in where healthcare is not taken seriously yet unlike the US or the UK. Use it during emergencies or regular procedures; every medical facility requires these hemostatic agents.
In recent developments, scientists were testing a new variety of polymer and happened to stumble over one particular combination that, unlike other coagulating agents, did not swell up. Immediately the chemical formula of the substance was modified. Since it is not a drug, it has no visible impact on the body. It does not cause the blood to swell up to form the clot. Instead, it speeds up the process and assists to seal the wound sooner than ever. The utility and efficacy can be sealed by the fact that even the military is interested in the product!
The market is wide and has a lot to offer. Be it the inclusion of topical hemostasis, advanced hemostasis, or infusible ones; the key products have caused a storm in a teacup. The enzymes that typically assist in topical hemostatic procedures or coagulation are cellulose, collagen, gelatin, polysaccharides and so on and so forth.
Similarly, when it comes to infusion based induced clotting; the platelets from a donor, frozen plasma, prothrombin complexes, or even a FVIII derived from the blood can be used to accelerate the process. These agents have found their ways into operation theatres that deal with trauma, hemophilia, strokes, thrombosis, myocardial infraction et al. did you know that hemorrhage contributed to 80% of the trauma death? Every 1 out of 10 patients succumbs to traumatic injuries. Therefore, it is crucial that bleeding during surgery is controlled to an extent where the chances of survival can be high.
Geographically, the North American region has dominated the market and occupies more than 35% of the share when it comes to using the hemostatic devices. Not only is the revenue from the area very high, but also growing medical awareness and technological developments have added to its consumer base. The developments in the field have attracted investors and the interest of the government to invest in the market to boost research. Following the market, suit is the European and Asia Pacific regions. Notably, the use of Haemostatic devices in Germany, France, and the UK have been significant in spite of various challenges.
Check out Market Data Forecast’s comprehensive reports with in-depth analysis of the Haemostatic Agents Market a free research sample can also be availed. Stay tuned for trending news stories about the latest technologies and interesting Healthcare tit-bits.
The post Haemostatic Agents Market | Do Not Lose That Blood appeared first on Market Reports Web.